Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,670.00 | |
50 mg | 6-8 weeks | $ 2,180.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM. |
Targets&IC50 | MCL1:0.03 nM (ki) |
In vitro | Mcl1-IN-9 inhibits growth of Mcl-1 dependent tumor cell lines in the nanomolar range. |
In vivo | Mcl1-IN-9 inhibits the growth of?triple negative breast cancer xenografts and hematological at well tolerated doses. |
Molecular Weight | 639.18 |
Formula | C37H39ClN4O4 |
CAS No. | 1810769-31-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mcl1-IN-9 1810769-31-3 Apoptosis BCL Mcl1 IN 9 Mcl-1-IN-9 Mcl1IN9 inhibitor inhibit